SVWA
NGVT icon

Sarver Vrooman Wealth Advisors’s Ingevity NGVT Stock Holding History

Sarver Vrooman Wealth Advisors’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2
Closed -$79 – 135
2025
Q1 		$79 Buy
+2
New +$89 ﹤0.01% 125

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sarver Vrooman Wealth Advisors's NGVT Position: Q2 2025 in Review

Sarver Vrooman Wealth Advisors sold out of Ingevity (NGVT) in Q2 2025, closing a stake of 2 shares — an estimated $79 sold.

Sarver Vrooman Wealth Advisors first reported a position in NGVT in Q1 2025 and held it in 1 quarter. The position peaked at $79 in Q1 2025. 269 funds tracked by Wall St. Rank hold NGVT as of Q2 2025.

  • Sarver Vrooman Wealth Advisors reported no remaining Ingevity position as of Q2 2025 after selling out during the quarter.
  • Sarver Vrooman Wealth Advisors sold 2 Ingevity shares in Q2 2025, an estimated $79.
  • Sarver Vrooman Wealth Advisors first reported a position in Ingevity in Q1 2025 and held it in 1 quarter.
  • Sarver Vrooman Wealth Advisors's Ingevity position peaked at $79 in Q1 2025.
  • 269 funds tracked by Wall St. Rank held Ingevity as of Q2 2025.

Based on Sarver Vrooman Wealth Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.